Tags: cancer | drug | shortage | pharmaceuticals | scarcity | hospitals | surgery

Cancer Drug Shortage Reported in U.S.

Wednesday, 16 Nov 2011 04:14 PM


Supplies are scarce for 168 drugs -- compared to just 56 drugs reported scarce in 2006, according to the FDA.

Most of the affected drugs are those provided in a hospital setting -- including cancer drugs, anesthetics for those undergoing surgery, and electrolytes for IV feeding. The cancer drugs are among the worst hit, putting some half a million patients at risk.

Researchers at IMS Institute for Healthcare Informatics believe some drugmakers have just stopped making certain medications in recent years. One hundred companies supply the 168 products initially reported in short supply. Some of the scarce drugs are produced by only one or two companies, IMS executive director Murray Aitken said. With just a few suppliers, there's not a lot of flexibility should one have a manufacturing problem.

"Part of the story is there may not be sufficient economic incentive currently in this sector of the market," Aitken added.

The corporations supplying the most drugs on the shortage list were Hospira, Inc. and Teva Pharmaceuticals USA. Others included Novartis AG, Watson Pharmaceuticals, Pfizer, and Baxter Healthcare, researchers report.


© HealthDay

 
1Like our page
2Share
Health-Wire
The U.S. drug shortage includes medications for cancer.
cancer,drug,shortage,pharmaceuticals,scarcity,hospitals,surgery,medications,
179
2011-14-16
Wednesday, 16 Nov 2011 04:14 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved